Zurcher Kantonalbank Zurich Cantonalbank Sells 1,943 Shares of Oscar Health, Inc. (NYSE:OSCR)

Zurcher Kantonalbank Zurich Cantonalbank decreased its position in shares of Oscar Health, Inc. (NYSE:OSCR) by 7.9% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 22,626 shares of the company’s stock after selling 1,943 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Oscar Health were worth $207,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Precision Wealth Strategies LLC bought a new stake in shares of Oscar Health during the third quarter valued at approximately $60,000. SG Americas Securities LLC purchased a new stake in Oscar Health in the 3rd quarter worth $62,000. Brown Advisory Inc. bought a new position in shares of Oscar Health during the 3rd quarter valued at about $83,000. Amalgamated Bank grew its position in shares of Oscar Health by 10.6% during the third quarter. Amalgamated Bank now owns 15,762 shares of the company’s stock valued at $88,000 after purchasing an additional 1,516 shares in the last quarter. Finally, QRG Capital Management Inc. bought a new stake in shares of Oscar Health in the third quarter worth about $117,000. Institutional investors own 75.70% of the company’s stock.

Oscar Health Stock Performance

NYSE:OSCR opened at $19.78 on Wednesday. The firm has a market capitalization of $4.54 billion, a PE ratio of -16.48 and a beta of 1.66. The stock’s fifty day moving average is $15.35 and its 200 day moving average is $11.86. Oscar Health, Inc. has a fifty-two week low of $4.72 and a fifty-two week high of $20.60. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.19 and a current ratio of 1.19.

Oscar Health (NYSE:OSCR) last announced its earnings results on Wednesday, February 7th. The company reported ($0.66) earnings per share for the quarter, beating the consensus estimate of ($0.74) by $0.08. Oscar Health had a negative net margin of 4.62% and a negative return on equity of 29.99%. The business had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.43 billion. During the same quarter in the prior year, the firm posted ($1.05) earnings per share. The business’s revenue for the quarter was up 43.9% on a year-over-year basis. On average, sell-side analysts anticipate that Oscar Health, Inc. will post -0.23 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on OSCR shares. The Goldman Sachs Group increased their price target on Oscar Health from $8.00 to $16.00 and gave the company a “neutral” rating in a research note on Friday, February 9th. Wells Fargo & Company raised their target price on shares of Oscar Health from $12.00 to $20.00 and gave the company an “overweight” rating in a report on Thursday, February 15th. Raymond James assumed coverage on shares of Oscar Health in a research report on Friday, March 22nd. They issued an “outperform” rating and a $20.00 price target on the stock. Finally, TheStreet upgraded shares of Oscar Health from a “d” rating to a “c-” rating in a research report on Wednesday, February 21st. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $13.50.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.